 |
| Date | Title | | | 01/27/10 | Amylin Pharmaceuticals Reports 2009 Financial Results| 2009 Non-GAAP Operating Loss Improves by 57% Over 2008SAN DIEGO, Jan. 27, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2009. The Company reported total revenue of $758.4 million for the year ended December 31, 2009, which includes net product sales of $754.0 million. Non-GAAP operating loss was $58.7 million for the year, compared to $137.2 million for 2008. Net loss excluding restructuri... |
|  | | 01/20/10 | Amylin Pharmaceuticals to Webcast Year-End Financial Results| SAN DIEGO, Jan. 20, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2009 on Wednesday, January 27, 2010 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. On the same date post-market, Amylin will release financial results for the fourth quarter and year ended December 31, 2009.
The call will be webcast live throug... |
|  | | 01/11/10 | Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference| SAN FRANCISCO, Jan. 11, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced the 2010 corporate priorities that will position the Company to address the dual epidemics of diabetes and obesity, achieve positive operating cash flow by the end of the year and place the Company on the path to operating profitability by the end of 2011. The news was presented by Daniel M. Bradbury, president and chief executive officer, at the 28th Annual J.P. Morgan Healthcare... |
|  | | 01/04/10 | Amylin Pharmaceuticals to Present at J.P. Morgan Healthcare Conference| SAN DIEGO, Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2010 at 6:30 p.m. ET / 3:30 p.m. PT. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.
The live presentation and break-out session will be webcast, and a recording will be made available following the event. The webcast and ... |
|  |
|
 |
 Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|